{"id":52098,"date":"2022-12-16T19:02:19","date_gmt":"2022-12-16T18:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/microbial-fermentation-technology-market-trends-analysis-report-2022-researchandmarkets-com\/"},"modified":"2022-12-16T19:02:19","modified_gmt":"2022-12-16T18:02:19","slug":"microbial-fermentation-technology-market-trends-analysis-report-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/microbial-fermentation-technology-market-trends-analysis-report-2022-researchandmarkets-com\/","title":{"rendered":"Microbial Fermentation Technology Market Trends\/Analysis Report 2022 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Microbial Fermentation Technology Market Size, Share & Trends Analysis Report by Application (Antibiotics, Vaccines), by End-use (Biopharmaceutical Companies), by Region, and Segment Forecasts, 2022-2030”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global microbial fermentation technology market size is expected to reach USD 49.4 billion by 2030 and is expected to expand at a CAGR of 6.0% from 2022 to 2030\n<\/p>\n

\nSince fermentation is observed to be of utmost importance in the manufacturing of biopharmaceuticals, there is also a growing demand for microbial fermentation technology in biopharmaceutical manufacturing. This has led to increasing collaborations and developments in this market space.\n<\/p>\n

\nFor instance, in September 2021, BIOVECTRA and ABEC collaboratively announced that the latter company would provide CSR single-use microbial fermentation solutions to expand BIOVECTRA’s manufacturing capabilities. The newly installed solutions are expected to provide a faster turnaround time with high-growth microbial fermentation on large scale.\n<\/p>\n

\nMoreover, in September 2022, Cargill and Genomatica along with Cyclone Engineers are working on a project to scale up the bioreactor fermentation processing. This project is a part of the National Biotechnology and Biomanufacturing Initiative with a grant of USD 2.5 million.\n<\/p>\n

\nFurthermore, technological advances in microbial fermentation platforms are also expected to supplement the market growth. For instance, several metabolic engineering approaches have been developed by researchers to enhance the performance of microbial cell factories used for the production of complex biologics or small molecules. Such continuous developments in this market space are likely to increase the adoption of this technology in biomanufacturing.\n<\/p>\n

\nAdditionally, various medications and vaccines, such as hormones, antibody fragments, and pneumococcal vaccines, are bio-manufactured using microbial fermentation techniques. Bacterial cells are often resistant to shear damage, enabling the use of high-shear radial impeller systems and high agitation rates.\n<\/p>\n

\nThis gives the fermentors a high mass transfer potential, allowing them to accommodate fast metabolizing, high-cell density microbial cell cultivations and increasing the quantity of product that the bioprocesses can produce. Thus, with the increasing adoption of SUB fermentors for bacterial fermentation, the market is likely to witness significant growth in the coming years.\n<\/p>\n

\nMicrobial Fermentation Technology Market Report Highlights<\/strong>\n<\/p>\n